featured
EGFR and BRAF Inhibition Effective in BRAF-Mutant CRC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)
J. Clin. Oncol 2020 Dec 23;[EPub Ahead of Print], S Kopetz, KA Guthrie, VK Morris, HJ Lenz, AM Magliocco, D Maru, Y Yan, R Lanman, G Manyam, DS Hong, A Sorokin, CE Atreya, LA Diaz, C Allegra, KP Raghav, SE Wang, CH Lieu, SL McDonough, PA Philip, HS HochsterFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.